Navigation Links
VMS BioMarketing Clinical Nurse Educators Will Provide Education to Support Needs of Women With Breast Cancer
Date:10/11/2017

INDIANAPOLIS, Oct. 11, 2017 /PRNewswire/ -- VMS BioMarketing, a leading provider of patient support solutions, has announced the development of a nationwide oncology Clinical Nurse Educator (CNE) network, which will launch this week. The VMS CNEs will address a growing need for communication among health care professionals to enhance the patient care experience by delivering peer-to-peer education programs to physicians, nurses, office staff, and other health care professionals to help women who have been diagnosed and are being treated for breast cancer.

VMS CNEs will deliver peer-to-peer education programs to physicians, nurses, office staff, and other healthcare professionals to help women who have been diagnosed and are being treated for breast cancer.
VMS CNEs will deliver peer-to-peer education programs to physicians, nurses, office staff, and other healthcare professionals to help women who have been diagnosed and are being treated for breast cancer.

According to the American Cancer Society, breast cancer is the most common cancer in American women, except for skin cancers. An estimated 252,710 women will be diagnosed with breast cancer this year, and 40,610 will die of the disease. Currently, the average risk of a woman in the United States developing breast cancer sometime in her life is about 12 percent 1

"Women who are affected by this devastating disease need physical, psychological, and emotional support," said Chris Field, director of strategic account management at VMS BioMarketing. "VMS is very pleased to provide additional education for health care professionals about treatments for breast cancer to help health care professionals, patients, and caregivers better understand the disease. Education will include how medication works, how and when to take their medication, what side effects if any to expect and how to manage them in their daily life, and how to connect with support resources patients need."

The CNEs in the VMS oncology educator network are highly specialized leaders in their field, with both clinical expertise in caring for people with chronic and life-threatening diseases as well as extensive skills in patient and provider education. In September, the field-based CNE team visited VMS BioMarketing in Indianapolis for onboarding, followed by online seminars. 

"The launch of this Clinical Nurse Educator network is particularly timely, as October is Breast Cancer Awareness Month," said Field. "VMS urges women to get regular screenings to find breast cancer early." The American Cancer Society has screening guidelines for women at average risk of breast cancer and for those at higher-than-average risk for breast cancer at the following link. https://www.cancer.org/healthy/find-cancer-early/cancer-screening-guidelines/american-cancer-society-guidelines-for-the-early-detection-of-cancer.html

About VMS BioMarketing:

VMS BioMarketing is a leading provider of patient support solutions focused on empowering health care providers and patients through education, training, and ongoing health coaching. For more than 20 years, VMS has been dedicated to enabling Clinical Nurse Educators to provide the personalized support necessary to help patients successfully start and stay on therapy. VMS clients include the world's leading pharmaceutical and biotechnology companies. To learn more, please visit www.vmsbiomarketing.com.

Contact:
Abigail Mallon  
317-805-6600, Ext. 225
Abigail.Mallon@vmsbiomarketing.com

1American Cancer Society. https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html

View original content with multimedia:http://www.prnewswire.com/news-releases/vms-biomarketing-clinical-nurse-educators-will-provide-education-to-support-needs-of-women-with-breast-cancer-300534822.html


'/>"/>
SOURCE VMS BioMarketing
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnologys CYT003 for the Treatment of Allergic Asthma
2. Positive Clinical Breast Cancer Data Presented for NuView’s Molecular Imaging Biomarker NLS-VPAC1
3. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
4. Ingenuity Systems and GeneInsight to Deliver an Interpretation and Reporting Workflow Solution to Clinical Laboratories
5. Greenwood Genetic Center Selects Cartagenia BENCHlab NGS, CNV Solutions for Clinical Data Analysis
6. Clinical Trials and Medical Research in Texas Create Jobs and Save Lives
7. Best Practices for Lean Six Sigma in Clinical Development and R&D, New Xtalks Life Sciences Webinar
8. Medical University of South Carolina Selects Elseviers Interdisciplinary Care Planning and Clinical Documentation Solution
9. Clinilabs Launches Research Volunteer Authentication Initiative Choosing Verified Clinical Trials to Stop Dual Enrollment in Clinical Trials
10. ISPE Releases New Guidance for Standardizing Use of Booklet Labels in Global Clinical Trials
11. Trigemina Receives ISP Approval of Clinical Study Protocol for TI-001 Phase 2 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/11/2019)... ... January 11, 2019 , ... Boekel ... automated collection of donor blood. This advanced and intuitive medical device was ... incorporates the functionality needed for the busiest donor stations with new-to-the industry features ...
(Date:1/10/2019)... ... ... adopted from a local shelter when he was around two years old. According to ... after he was adopted, he tore his right cruciate ligament. Though he had his ... a traumatic injury. , Sure enough, when Rascal was about nine years old, he began ...
(Date:1/10/2019)... ... January 08, 2019 , ... VGI Medical was founded in 2007 ... in bringing innovation to the market including VerteLoc, CerLoc, SiJoin and VerteLP. The VerteLoc ... utilizing a unique patented dual geometric design to limit motion of the affected spinal ...
(Date:1/8/2019)... ... ... The American Society of Gene and Cell Therapy’s (ASGCT) first class of ... industry leaders identified by the ASGCT board of directors. In total, the Society will ... members designing transformative pilot studies in gene and cell therapy as they prepare to ...
Breaking Biology Technology:
(Date:1/7/2019)... , ... January 07, 2019 , ... ... and Artificial Intelligence solutions for precision health in oncology and other key therapeutic ... Morgan’s exclusive meeting of investors, entrepreneurs and executives spanning the entire healthcare landscape, ...
(Date:1/4/2019)... ... January 02, 2019 , ... ... noteworthy, as the life science tools and service supplier turned 40 in 2018 ... catalog. The catalog features not just part numbers like most catalogs, but rather, ...
(Date:12/27/2018)... ... December 27, 2018 , ... AxioMed ... its new Boston facility, and is now raising growth capital to ramp up ... market share against inferior ball and socket discs. The capital raise is targeted ...
Breaking Biology News(10 mins):